Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
about
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Disruptive chemicals, senescence and immortalityEnvironmental immune disruptors, inflammation and cancer riskMacrophage-tumor cell interactions regulate the function of nitric oxideThe induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrestInflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cellsImmunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitorRole of inflammation and oxidative stress mediators in gliomas.Cancer: A Tale of Aberrant PRR Response.Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines.Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.Millettia pachycarpa exhibits anti-inflammatory activity through the suppression of LPS-induced NO/iNOS expression.
P2860
Q26827810-49912F55-8C82-4B77-9E0C-843B56CF0889Q27026235-A412724F-469E-4734-AFF5-E8A47A668F88Q28080870-68A4CB91-F701-426B-B29B-BB61A0D90AA7Q28384490-72DB6D4F-B7AD-47DF-82EE-7F35C61D019EQ28484878-412BBB7D-31CD-4589-B10C-E5C182E7D30AQ33575734-6BBA5D0F-6C43-401F-8680-A86A420AE6F8Q34159639-BF287ADA-F723-44AF-A579-BE57789667E9Q34962856-E6B496D2-E38E-4565-B904-F4D9ADC59A8DQ35057027-0AFB81D5-7712-46F4-B2C1-F8E83536455BQ37328326-0E323EDC-910E-4923-A214-873F3E7CCBD2Q38208308-4259EB80-FF10-4E31-846C-DAA916E15AC7Q39816980-12E62EE3-B156-4899-A340-56D9AC6C0B52Q39968256-5DF3625D-526B-4863-BAA1-B5A267B81D34Q42616887-C94A368F-A224-4368-95C2-D66CDF999085Q48258428-E71EB0E9-C179-41CA-811B-5B71F9BAA1E1
P2860
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
@en
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
@nl
type
label
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
@en
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
@nl
prefLabel
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
@en
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
@nl
P2093
P2860
P1433
P1476
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
@en
P2093
Anne B Hofseth
Darren D Browning
Lorne J Hofseth
Mitzi Nagarkatti
Prakash S Nagarkatti
P2860
P304
P356
10.1158/0008-5472.CAN-07-2238
P407
P577
2007-10-01T00:00:00Z